153 related articles for article (PubMed ID: 15906357)
21. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.
Pontisso P; Quarta S; Caberlotto C; Beneduce L; Marino M; Bernardinello E; Tono N; Fassina G; Cavalletto L; Gatta A; Chemello L
Int J Cancer; 2006 Aug; 119(4):735-40. PubMed ID: 16550605
[TBL] [Abstract][Full Text] [Related]
22. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
23. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
24. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
[TBL] [Abstract][Full Text] [Related]
25. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.
Yagmur E; Rizk M; Stanzel S; Hellerbrand C; Lammert F; Trautwein C; Wasmuth HE; Gressner AM
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):755-61. PubMed ID: 17700260
[TBL] [Abstract][Full Text] [Related]
26. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
Sarwar S; Khan AA; Tarique S
J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
[TBL] [Abstract][Full Text] [Related]
27. Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients.
Gil-Gómez A; Rojas Á; Liu CH; Gallego-Duran R; Muñoz-Hernandez R; Fassina G; Pontisso P; Ampuero J; Romero-Gómez M
World J Gastroenterol; 2021 Dec; 27(48):8343-8356. PubMed ID: 35068873
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
29. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.
Porta C; De Amici M; Quaglini S; Paglino C; Tagliani F; Boncimino A; Moratti R; Corazza GR
Ann Oncol; 2008 Feb; 19(2):353-8. PubMed ID: 17962206
[TBL] [Abstract][Full Text] [Related]
30. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
[TBL] [Abstract][Full Text] [Related]
31. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P
PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of serum endoglin level in Egyptian hepatocellular carcinoma patients.
Elnemr DM; Abdel-Azeez HA; Labib HA; Abo-Taleb FM
Clin Lab; 2012; 58(9-10):1023-8. PubMed ID: 23163119
[TBL] [Abstract][Full Text] [Related]
33. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
[TBL] [Abstract][Full Text] [Related]
34. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?
Morace C; Cucunato M; Bellerone R; De Caro G; Crinò S; Fortiguerra A; Spadaro F; Zirilli A; Alibrandi A; Consolo P; Luigiano C; Resta ML; Ferraù O; Spadaro A
Eur J Intern Med; 2012 Sep; 23(6):e157-61. PubMed ID: 22863442
[TBL] [Abstract][Full Text] [Related]
36. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
37. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
38. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
39. A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.
Chen M; Zheng T; Han S; Zhang L; Bai Y; Fang X; Ding SZ; Yang Y
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):215-21. PubMed ID: 25312778
[TBL] [Abstract][Full Text] [Related]
40. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]